Literature DB >> 10025090

Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones.

W Riedel1, H Layka, G Neeck.   

Abstract

To study the hormonal perturbations in FMS patients we injected sixteen FMS patients and seventeen controls a cocktail of the hypothalamic releasing hormones: Corticotropin-releasing hormone (CRH), Thyrotropin-releasing hormone (TRH), Growth hormone-releasing hormone (GHRH), and Luteinizing hormone-releasing hormone (LHRH) and observed the hormonal secretion pattern of the pituitary together with the hormones of the peripheral endocrine glands. We found in FMS patients elevated basal values of ACTH and cortisol, lowered basal values of insulin-like growth factor I (IGF-I) and of triiodothyronine (T3), elevated basal values of follicle-stimulating hormone (FSH) and lowered basal values of estrogen. Following injection of the four releasing-hormones, we found in FMS patients an augmented response of ACTH, a blunted response of TSH, while the prolactin response was exaggerated. The effects of LHRH stimulation were investigated in six FMS patients and six controls and disclosed a significantly blunted response of LH in FMS. We explain the deviations of hormonal secretion in FMS patients as being caused by chronic stress, which, after being perceived and processed by the central nervous system (CNS), activates hypothalamic CRH neurons. CRH, on the one hand, activates the pituitary-adrenal axis, but also stimulates at the hypothalamic level somatostatin secretion which, in turn, causes inhibition of GH and TSH at the pituitary level. The suppression of gonadal function may also be attributed to elevated CRH by its ability to inhibit hypothalamic LHRH release, although it could act also directly on the ovary by inhibiting FSH-stimulated estrogen production. We conclude that the observed pattern of hormonal deviations in FMS patients is a CNS adjustment to chronic pain and stress, constitutes a specific entity of FMS, and is primarily evoked by activated CRH neurons.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10025090     DOI: 10.1007/s003930050242

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  27 in total

Review 1.  Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide.

Authors:  Salih Ozgocmen; Huseyin Ozyurt; Sadik Sogut; Omer Akyol
Journal:  Rheumatol Int       Date:  2005-11-20       Impact factor: 2.631

2.  [Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain].

Authors:  C Sommer; W Häuser; K Gerhold; P Joraschky; F Petzke; T Tölle; N Uçeyler; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

3.  Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia.

Authors:  Samuel A McLean; David A Williams; Phyllis K Stein; Richard E Harris; Angela K Lyden; Gail Whalen; Karen M Park; Israel Liberzon; Ananda Sen; Richard H Gracely; James N Baraniuk; Daniel J Clauw
Journal:  Neuropsychopharmacology       Date:  2006-08-23       Impact factor: 7.853

4.  Nociceptive aspects of fibromyalgia.

Authors:  A A Larson; K J Kovács
Journal:  Curr Pain Headache Rep       Date:  2001-08

Review 5.  Behavioural, physiological, neuro-endocrine and molecular responses of cattle against heat stress: an updated review.

Authors:  S R Mishra
Journal:  Trop Anim Health Prod       Date:  2021-07-13       Impact factor: 1.559

6.  Hypothalamic involvement in chronic migraine.

Authors:  M F Peres; M Sanchez del Rio; M L Seabra; S Tufik; J Abucham; J Cipolla-Neto; S D Silberstein; E Zukerman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

Review 7.  Adult growth hormone deficiency in patients with fibromyalgia.

Authors:  Robert M Bennett
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

Review 8.  Growth hormone in musculoskeletal pain states.

Authors:  Robert Bennett
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

9.  Association between thyroid autoimmunity and fibromyalgic disease severity.

Authors:  Laura Bazzichi; Alessandra Rossi; Tiziana Giuliano; Francesca De Feo; Camillo Giacomelli; Arianna Consensi; Antonio Ciapparelli; Giorgio Consoli; Liliana Dell'Osso; Stefano Bombardieri
Journal:  Clin Rheumatol       Date:  2007-05-09       Impact factor: 2.980

Review 10.  Neuroendocrine abnormalities in fibromyalgia.

Authors:  Gail K Adler; Valdis F Manfredsdottir; Katharine W Creskoff
Journal:  Curr Pain Headache Rep       Date:  2002-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.